vs
Side-by-side financial comparison of OXFORD INDUSTRIES INC (OXM) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
OXFORD INDUSTRIES INC is the larger business by last-quarter revenue ($307.3M vs $158.6M, roughly 1.9× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs -20.7%, a 91.9% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs -0.2%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $-47.9M).
Oxford Industries, Inc. is a publicly traded clothing company in the United States that specializes in high-end clothing and apparel. The company carries many major labels, including Tommy Bahama, Lilly Pulitzer, Johnny Was and Southern Tide.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
OXM vs STOK — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $307.3M | $158.6M |
| Net Profit | $-63.7M | $112.9M |
| Gross Margin | 60.3% | — |
| Operating Margin | -27.7% | 70.2% |
| Net Margin | -20.7% | 71.2% |
| Revenue YoY | -0.2% | 3661.1% |
| Net Profit YoY | -1517.6% | 528.0% |
| EPS (diluted) | $-4.28 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $307.3M | — | ||
| Q3 25 | $403.1M | — | ||
| Q2 25 | $392.9M | — | ||
| Q1 25 | — | $158.6M | ||
| Q4 24 | $308.0M | $22.6M | ||
| Q3 24 | $419.9M | — | ||
| Q2 24 | $398.2M | — | ||
| Q1 24 | $404.4M | — |
| Q4 25 | $-63.7M | — | ||
| Q3 25 | $16.7M | — | ||
| Q2 25 | $26.2M | — | ||
| Q1 25 | — | $112.9M | ||
| Q4 24 | $-3.9M | $-10.5M | ||
| Q3 24 | $40.6M | — | ||
| Q2 24 | $38.4M | — | ||
| Q1 24 | $-60.1M | — |
| Q4 25 | 60.3% | — | ||
| Q3 25 | 61.4% | — | ||
| Q2 25 | 64.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 63.1% | — | ||
| Q3 24 | 63.1% | — | ||
| Q2 24 | 64.9% | — | ||
| Q1 24 | 60.9% | — |
| Q4 25 | -27.7% | — | ||
| Q3 25 | 6.3% | — | ||
| Q2 25 | 9.2% | — | ||
| Q1 25 | — | 70.2% | ||
| Q4 24 | -2.0% | -60.4% | ||
| Q3 24 | 12.5% | — | ||
| Q2 24 | 13.2% | — | ||
| Q1 24 | -20.1% | — |
| Q4 25 | -20.7% | — | ||
| Q3 25 | 4.1% | — | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | — | 71.2% | ||
| Q4 24 | -1.3% | -46.4% | ||
| Q3 24 | 9.7% | — | ||
| Q2 24 | 9.6% | — | ||
| Q1 24 | -14.9% | — |
| Q4 25 | $-4.28 | — | ||
| Q3 25 | $1.12 | — | ||
| Q2 25 | $1.70 | — | ||
| Q1 25 | — | $1.90 | ||
| Q4 24 | $-0.25 | $-0.15 | ||
| Q3 24 | $2.57 | — | ||
| Q2 24 | $2.42 | — | ||
| Q1 24 | $-3.72 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.0M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $528.0M | $350.1M |
| Total Assets | $1.3B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.0M | — | ||
| Q3 25 | $6.9M | — | ||
| Q2 25 | $8.2M | — | ||
| Q1 25 | — | $274.8M | ||
| Q4 24 | $7.0M | $128.0M | ||
| Q3 24 | $18.4M | — | ||
| Q2 24 | $7.7M | — | ||
| Q1 24 | $7.6M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $29.0M | — |
| Q4 25 | $528.0M | — | ||
| Q3 25 | $597.1M | — | ||
| Q2 25 | $592.4M | — | ||
| Q1 25 | — | $350.1M | ||
| Q4 24 | $612.2M | $229.0M | ||
| Q3 24 | $621.6M | — | ||
| Q2 24 | $592.9M | — | ||
| Q1 24 | $560.9M | — |
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | — | $406.9M | ||
| Q4 24 | $1.2B | $271.6M | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.1B | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.05× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.1M | $131.8M |
| Free Cash FlowOCF − Capex | $-47.9M | $131.7M |
| FCF MarginFCF / Revenue | -15.6% | 83.0% |
| Capex IntensityCapex / Revenue | 12.6% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $-79.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.1M | — | ||
| Q3 25 | $83.5M | — | ||
| Q2 25 | $-3.9M | — | ||
| Q1 25 | — | $131.8M | ||
| Q4 24 | $-18.2M | $-23.2M | ||
| Q3 24 | $88.8M | — | ||
| Q2 24 | $32.9M | — | ||
| Q1 24 | $74.9M | — |
| Q4 25 | $-47.9M | — | ||
| Q3 25 | $52.3M | — | ||
| Q2 25 | $-27.4M | — | ||
| Q1 25 | — | $131.7M | ||
| Q4 24 | $-56.9M | $-23.2M | ||
| Q3 24 | $47.2M | — | ||
| Q2 24 | $21.0M | — | ||
| Q1 24 | $55.3M | — |
| Q4 25 | -15.6% | — | ||
| Q3 25 | 13.0% | — | ||
| Q2 25 | -7.0% | — | ||
| Q1 25 | — | 83.0% | ||
| Q4 24 | -18.5% | -102.7% | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 5.3% | — | ||
| Q1 24 | 13.7% | — |
| Q4 25 | 12.6% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 6.0% | — | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 12.6% | 0.2% | ||
| Q3 24 | 9.9% | — | ||
| Q2 24 | 3.0% | — | ||
| Q1 24 | 4.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.00× | — | ||
| Q2 25 | -0.15× | — | ||
| Q1 25 | — | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.19× | — | ||
| Q2 24 | 0.86× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OXM
| Sales Channel Retail | $162.9M | 53% |
| Sales Channel Wholesale | $61.3M | 20% |
| Johnny Was | $45.4M | 15% |
| Sales Channel Food And Beverage | $29.3M | 10% |
| Other Foreign Countries | $9.0M | 3% |
STOK
Segment breakdown not available.
